MIM
GRTS

MetLife Investment Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

MetLife Investment Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,275
Closed -$93.2K – 2931
2024
Q1 		$93.2K Sell
36,275
-10,418
-22% -$25.5K ﹤0.01% 2572
2023
Q4 		$95.3K Hold
46,693
– – ﹤0.01% 2630
2023
Q3 		$80.3K Hold
46,693
– – ﹤0.01% 2695
2023
Q2 		$91.1K Buy
+46,693
New +$109K ﹤0.01% 2732
2022
Q1 		– Sell
-15,799
Closed -$203K – 2778
2021
Q4 		$203K Buy
15,799
+5,410
+52% +$59.9K ﹤0.01% 2045
2021
Q3 		$112K Sell
10,389
-6,065
-37% -$55.2K ﹤0.01% 2394
2021
Q2 		$150K Buy
16,454
+12,198
+287% +$113K ﹤0.01% 2324
2021
Q1 		$40.1K Buy
+4,256
New +$58.6K ﹤0.01% 2287
2020
Q3 		– Sell
-15,554
Closed -$103K – 2339
2020
Q2 		$103K Buy
15,554
+2,612
+20% +$17.6K ﹤0.01% 2241
2020
Q1 		$75.3K Buy
+12,942
New +$109K ﹤0.01% 2198
2019
Q4 		– Sell
-13,449
Closed -$116K – 2336
2019
Q3 		$116K Hold
13,449
– – ﹤0.01% 2250
2019
Q2 		$150K Buy
+13,449
New +$154K ﹤0.01% 2192

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MetLife Investment Management's GRTS Position: Q2 2024 in Review

MetLife Investment Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 36,275 shares — an estimated $93.2K sold.

MetLife Investment Management first reported a position in GRTS in Q2 2019 and held it in 12 quarters. The position peaked at $203K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • MetLife Investment Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 36,275 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $93.2K.
  • MetLife Investment Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • MetLife Investment Management's Gritstone bio, Inc. Common Stock position peaked at $203K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.